Skip to main content

BoltRock Holdings LLC's Form 4 filing

CitroTech Inc. (CITR) · filed Oct 15, 2025

Accession no.
0001193125-25-240339
Filed
Oct 15, 2025
Trade date
Jun 30-Sep 30, 2025
Filing delay
107 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction and 4 derivative transactions. It was filed 107 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
BoltRock Holdings LLCCIK 000206100710% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 3, 2025Common StockCConversionAcquired+2,166,667–F1–2,416,667Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 30, 2025Common StockJOtherAcquired+230,024–F2–719,007Direct
Sep 3, 2025Common StockCConversionDisposed−2,166,667–F1–69,007Direct
Sep 30, 2025Common StockPPurchaseAcquired+88,890–F3–95,674Direct
Sep 30, 2025Common StockPPurchaseAcquired+44,445–F5–44,445Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Each share of Series C Convertible Preferred Stock is convertible at any time at the option of the holder into 3.3333 shares of Common Stock. The Series C Convertible Preferred Stock has no expiration date.

Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.

F2

Represents shares of Series C Convertible Preferred Stock issued to the Reporting Person pursuant to an adjustment under the March 2025 Share Purchase Agreement to offset dilution from subsequent equity issuances.

Referenced by the price of 1 transaction in Table II.

F3

On September 30, 2025, the Reporting Person entered into a securities purchase agreement (the "Securities Purchase Agreement") with the Issuer, pursuant to which the Reporting Person purchased 26,667 shares of Series C Convertible Preferred Stock (the "Series C Shares") for an aggregate purchase price of $400,000 ($15.00 per Series C Share).

Referenced by the price of 1 transaction in Table II.

F5

In connection with the execution of the Securities Purchase Agreement, the Reporting Person also executed a common stock purchase warrant agreement (the "Warrant Agreement"), pursuant to which the Issuer issued a warrant to the Reporting Person. The Warrant Agreement entitles the Reporting Person to purchase from the Issuer up to 50% of the number of shares of Common Stock issuable upon full conversion of all the Series C Shares purchased by the Reporting Person, subject to the terms and conditions of the Warrant Agreement.

Referenced by the price of 1 transaction in Table II.

Remarks

The number of shares of Common Stock reported herein as beneficially owned by the Reporting Person reflects the 1-for-6 reverse stock split of the Issuer's Common Stock and Series A Preferred Stock effective August 28, 2025.

Read the full filing on SEC EDGAR (opens in a new tab)